Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimerās. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,073
Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
for
Active Surveillance, Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07023432
Phase2, Recruiting
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03819296
Phase1, Recruiting
Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors
for
Solid Tumor
Location: Houston TX, Gilbert AZ
Sponsor: Virogin Biotech Canada Ltd
Sex: All
Age: 18+
Code: NCT05266612
Phase1, Recruiting
Effect of the Amplifi⢠Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
for
End Stage Kidney Disease (ESRD)
Location: Houston TX, Boston MA
Sponsor: Amplifi Vascular, Inc.
Sex: All
Age: 18+
Code: NCT07211035
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Houston TX, San Antonio TX, Louisville KY, Chicago IL,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease
for
AML
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 65 - 70+
Code: NCT06973668
Phase2, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Bellaire TX, Houston TX, Katy TX, The Woodlands TX,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase3, Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
for
Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2,
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
for
Spina Bifida
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT06929572
Recruiting
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
for
Neoadjuvant Treatment, Thyroid Cancer
Location: Houston TX, Ann Arbor MI, Cleveland OH,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06959511
Phase2, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Houston TX, Dallas TX, Oklahoma City OK, Denver CO,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase1, Recruiting
SW-682 in Advanced Solid Tumors
for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Houston TX, Dallas TX, Scottsdale AZ, Cleveland OH,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06251310
Phase1, Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
for
Immune Thrombocytopenia (ITP)
Location: Houston TX, New Orleans LA, Washington D.C. DC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06721013
Phase1, Phase2, Recruiting
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT06826768
Phase1, Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion